Intrinsic Value of S&P & Nasdaq Contact Us

Illumina, Inc. ILMN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
61/100
4/7 Pass
SharesGrow Intrinsic Value
$143.90
+10.4%
Analyst Price Target
$147.13
+12.9%

Illumina, Inc. (ILMN) — Analyst outlook / Analyst consensus target is. Based on 50 analyst ratings, the consensus is bullish — 1 Strong Buy, 24 Buy, 19 Hold, 6 Sell.

The consensus price target is $147.13 (low: $110.00, high: $170.00), representing an upside of 12.9% from the current price $130.32.

Analysts estimate Earnings Per Share (EPS) of $4.13 and revenue of $4.33B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-7.69 vs est $4.13 (missed -286.2%). 2025: actual $5.47 vs est $4.73 (beat +15.6%). Analyst accuracy: 16%.

ILMN Stock — 12-Month Price Forecast

$147.13
▲ +12.90% Upside
Average Price Target
Based on 50 Wall Street analysts offering 12-month price targets for Illumina, Inc., the average price target is $147.13, with a high forecast of $170.00, and a low forecast of $110.00.
The average price target represents a +12.90% change from the last price of $130.32.
Highest Price Target
$170.00
Average Price Target
$147.13
Lowest Price Target
$110.00

ILMN Analyst Ratings

Buy
50
Ratings
25 Buy
19 Hold
6 Sell
Based on 50 analysts giving stock ratings to Illumina, Inc. in the past 3 months
Rating breakdown
Strong Buy
1 2%
Buy
24 48%
Hold
19 38%
Sell
6 12%
50%
Buy
25 analysts
38%
Hold
19 analysts
12%
Sell
6 analysts

EPS Estimates — ILMN

16%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$7.69 vs Est $4.13 ▼ 153.7% off
2025 Actual $5.47 vs Est $4.73 ▲ 13.5% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

Revenue Estimates — ILMN

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $4.372B vs Est $4.332B ▲ 0.9% off
2025 Actual $4.342B vs Est $4.303B ▲ 0.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message